Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2026-03-04 @ 4:59 AM
Study NCT ID:
NCT00492206
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2007-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
Sponsor:
University of Pittsburgh
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
05-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |